ATE420078T1 - Pyrimidinonen als virale polymerase inhibitoren - Google Patents
Pyrimidinonen als virale polymerase inhibitorenInfo
- Publication number
- ATE420078T1 ATE420078T1 AT03700366T AT03700366T ATE420078T1 AT E420078 T1 ATE420078 T1 AT E420078T1 AT 03700366 T AT03700366 T AT 03700366T AT 03700366 T AT03700366 T AT 03700366T AT E420078 T1 ATE420078 T1 AT E420078T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- pyrimidinones
- polymerase inhibitors
- viral polymerase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0201179.9A GB0201179D0 (en) | 2002-01-18 | 2002-01-18 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE420078T1 true ATE420078T1 (de) | 2009-01-15 |
Family
ID=9929352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03700366T ATE420078T1 (de) | 2002-01-18 | 2003-01-15 | Pyrimidinonen als virale polymerase inhibitoren |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050130997A1 (de) |
| EP (1) | EP1470113B1 (de) |
| JP (1) | JP4498745B2 (de) |
| AT (1) | ATE420078T1 (de) |
| CA (1) | CA2473508A1 (de) |
| DE (1) | DE60325692D1 (de) |
| GB (1) | GB0201179D0 (de) |
| WO (1) | WO2003062211A1 (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004062613A2 (en) | 2003-01-13 | 2004-07-29 | Bristol-Myers Squibb Company | Hiv integrase inhibitors |
| DE602004028841D1 (de) | 2003-07-25 | 2010-10-07 | Centre Nat Rech Scient | Purin nucleoside für die behandlung von durch flavividrae verursachten krankheiten, einschliesslich hepatitis c |
| AU2003304416A1 (en) * | 2003-08-13 | 2005-03-07 | Bf Research Institute, Inc. | Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change |
| AR046938A1 (es) * | 2003-12-12 | 2006-01-04 | Merck & Co Inc | Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares |
| EP2626354A1 (de) | 2004-02-20 | 2013-08-14 | Boehringer Ingelheim International GmbH | Viren-Polymerasehemmer |
| JP4705164B2 (ja) | 2005-05-02 | 2011-06-22 | メルク・シャープ・エンド・ドーム・コーポレイション | Ｈｃｖｎｓ３プロテアーゼ阻害剤 |
| US7470664B2 (en) | 2005-07-20 | 2008-12-30 | Merck & Co., Inc. | HCV NS3 protease inhibitors |
| US8278322B2 (en) | 2005-08-01 | 2012-10-02 | Merck Sharp & Dohme Corp. | HCV NS3 protease inhibitors |
| CA2622639C (en) * | 2005-10-04 | 2012-01-03 | Istituto Di Recerche Di Biologia Molecolare P. Angeletti S.P.A. | Hiv integrase inhibitors |
| GB0609492D0 (en) | 2006-05-15 | 2006-06-21 | Angeletti P Ist Richerche Bio | Therapeutic agents |
| GB0612423D0 (en) | 2006-06-23 | 2006-08-02 | Angeletti P Ist Richerche Bio | Therapeutic agents |
| US8138164B2 (en) | 2006-10-24 | 2012-03-20 | Merck Sharp & Dohme Corp. | HCV NS3 protease inhibitors |
| CN101583372A (zh) | 2006-10-24 | 2009-11-18 | 默克公司 | Hcv ns3蛋白酶抑制剂 |
| EP2076278B1 (de) | 2006-10-24 | 2015-05-06 | Merck Sharp & Dohme Corp. | Makrozyklische HCV NS3-Proteasehemmer |
| KR101615500B1 (ko) | 2006-10-27 | 2016-04-27 | 머크 샤프 앤드 돔 코포레이션 | Ｈｃｖ ｎｓ3 프로테아제 억제제 |
| AU2007318164B2 (en) | 2006-10-27 | 2013-02-07 | Merck Sharp & Dohme Corp. | HCV NS3 protease inhibitors |
| GB0625345D0 (en) | 2006-12-20 | 2007-01-31 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| AU2007335962B2 (en) | 2006-12-20 | 2012-09-06 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Antiviral indoles |
| GB0625349D0 (en) | 2006-12-20 | 2007-01-31 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| CN102872461A (zh) | 2007-05-04 | 2013-01-16 | 弗特克斯药品有限公司 | 用于治疗hcv感染的组合治疗 |
| US7763630B2 (en) | 2007-06-06 | 2010-07-27 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| CN101801982A (zh) | 2007-07-17 | 2010-08-11 | P.安杰莱蒂分子生物学研究所 | 用于治疗丙型肝炎感染的大环吲哚衍生物 |
| CN101754974B (zh) | 2007-07-19 | 2016-02-03 | Msd意大利有限公司 | 作为抗病毒剂的大环化合物 |
| WO2009018657A1 (en) * | 2007-08-03 | 2009-02-12 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| CN103483251A (zh) | 2007-12-19 | 2014-01-01 | 贝林格尔.英格海姆国际有限公司 | 病毒聚合酶抑制剂 |
| JP2011518882A (ja) | 2008-04-28 | 2011-06-30 | メルク・シャープ・エンド・ドーム・コーポレイション | Ｈｃｖｎｓ３プロテアーゼ阻害剤 |
| PT2310095E (pt) | 2008-07-22 | 2012-11-16 | Angeletti P Ist Richerche Bio | Compostos de quinoxalina macrocílicos como inibidores da protease ns3 do hcv |
| SG172848A1 (en) | 2009-01-07 | 2011-08-29 | Scynexis Inc | Cyclosporine derivative for use in the treatment of hcv and hiv infection |
| JP2012517439A (ja) | 2009-02-06 | 2012-08-02 | エラン ファーマシューティカルズ，インコーポレイテッド | Ｊｕｎｎ−末端キナーゼの阻害薬 |
| US8143244B2 (en) | 2009-02-26 | 2012-03-27 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| US8741914B2 (en) | 2009-03-25 | 2014-06-03 | Abbvie Inc. | Antiviral compounds and uses thereof |
| EP2459582B1 (de) | 2009-07-30 | 2015-05-27 | Merck Sharp & Dohme Corp. | Hvc-ns3-proteasehemmer |
| US8383639B2 (en) | 2009-10-15 | 2013-02-26 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| KR101382730B1 (ko) | 2010-08-13 | 2014-04-08 | 에프. 호프만-라 로슈 아게 | 헤테로환형 항바이러스성 화합물 |
| US9328075B2 (en) * | 2011-05-05 | 2016-05-03 | St. Jude Children's Research Hospital | Pyrimidinone compounds and methods for treating influenza |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2260319B (en) * | 1991-10-07 | 1995-12-06 | Norsk Hydro As | Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity |
| DE19817265A1 (de) * | 1998-04-18 | 1999-10-21 | Bayer Ag | Verwendung von Dihydropyrimidinen als Arzneimittel und neue Stoffe |
| KR20010074949A (ko) * | 1998-09-04 | 2001-08-09 | 비로파마 인코포레이티드 | 바이러스성 감염 및 관련 질환의 치료 방법 또는 예방 방법 |
| GB0017676D0 (en) * | 2000-07-19 | 2000-09-06 | Angeletti P Ist Richerche Bio | Inhibitors of viral polymerase |
-
2002
- 2002-01-18 GB GBGB0201179.9A patent/GB0201179D0/en not_active Ceased
-
2003
- 2003-01-15 EP EP03700366A patent/EP1470113B1/de not_active Expired - Lifetime
- 2003-01-15 WO PCT/GB2003/000124 patent/WO2003062211A1/en active Application Filing
- 2003-01-15 CA CA002473508A patent/CA2473508A1/en not_active Abandoned
- 2003-01-15 AT AT03700366T patent/ATE420078T1/de not_active IP Right Cessation
- 2003-01-15 JP JP2003562091A patent/JP4498745B2/ja not_active Expired - Fee Related
- 2003-01-15 US US10/500,971 patent/US20050130997A1/en not_active Abandoned
- 2003-01-15 DE DE60325692T patent/DE60325692D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1470113B1 (de) | 2009-01-07 |
| JP2005524627A (ja) | 2005-08-18 |
| DE60325692D1 (de) | 2009-02-26 |
| CA2473508A1 (en) | 2003-07-31 |
| GB0201179D0 (en) | 2002-03-06 |
| JP4498745B2 (ja) | 2010-07-07 |
| EP1470113A1 (de) | 2004-10-27 |
| WO2003062211A1 (en) | 2003-07-31 |
| US20050130997A1 (en) | 2005-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60325692D1 (de) | Pyrimidinonen als virale polymerase inhibitoren | |
| DE60140127D1 (en) | Dihydroxypyrimidin-carbonsäuren als virale polymerase inhibitoren | |
| WO2004014852A3 (en) | Iminothiazolidinones as inhibitors of hcv replication | |
| CY1112108T1 (el) | Αναστολεις ιου ηπατιτιδας c | |
| TW200508220A (en) | Hepatitis C inhibitor compounds | |
| EA200700038A1 (ru) | Ингибиторы вирусных полимераз | |
| AU2003240488A1 (en) | Pyrazolo` 1,5a! pyrimidine compounds as antiviral agents | |
| WO2005054430A3 (en) | Hepatitis c virus inhibitors | |
| IS8448A (is) | Lifrarbólgu C-veirutálmar | |
| NZ514403A (en) | Fused-ring compounds and use thereof as drugs | |
| GT200200117A (es) | Derivados de nucleosidos | |
| BR0305259A (pt) | Inibidores de hcv ns5b polimerase | |
| ATE474827T1 (de) | Hcv-replikationshemmer | |
| WO2002069903A3 (en) | Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases | |
| DE69909756D1 (de) | Antivirale pyrimidinderivate | |
| UY28525A1 (es) | Péptidos macrociclicos activos contra en virus de la hepatitis c | |
| TW200745035A (en) | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors | |
| DE60101223D1 (de) | Antivirale pyrimidin nucleoside derivate | |
| ATE231149T1 (de) | (1,8)-naphthyridinderivate derivate mit antiviraler wirkung | |
| WO2006027628A3 (en) | Naphthalimide derivatives as antiviral agents | |
| EA200600046A1 (ru) | Производные 6-[2-(фосфонометокси)алкокси]пиримидинов (варианты), способ их получения (варианты), фармацевтическая композиция на их основе и способ лечения вирусной инфекции | |
| EA200400690A1 (ru) | Нуклеозиды, их препараты и их применение в качестве ингибиторов вирусных рнк-полимераз | |
| CA2480583A1 (en) | Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase | |
| EP1616967A3 (de) | Primer für die isothermische Amplifizierung und Genotypisierung des Hepatitis C Virus | |
| CY1114456T1 (el) | Αναστολεις ιικης πολυμερασης |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |